Playing a hot hand in cancer R&D, Pfizer scores its 4th drug approval in just 2 months

Pfizer’s hot hand in oncology continued this week with an FDA OK for glasdegib, an oral drug designed to throw a monkey wrench into the biology driving the hedgehog pathway in acute myeloid leukemia.